Health Carerss

Allergan's Vitae Buy Could Spark More Interest in Kadmon

Tickers in this article: AGN VTAE KDMN YHOO CELG

Hedge fund billionaire Dan Loeb owns a greater than 17% stake in the newly public developer of a drugs including those for treatment of psoriasis.

09/23/16 - 06:25 AM EDT

Cloudy Outlook for Aerie Pharma's Glaucoma Drug

Tickers in this article: AERI

When an experimental glaucoma drug is only marginally effective, one way to produce positive clinical trial results is to enroll patients with borderline glaucoma.

09/21/16 - 06:30 AM EDT

These 5 Biotech Stocks Are Ready for a Volatility Break

These 5 Biotech Stocks Are Ready for a Volatility Break

Tickers in this article: ACAD BMRN CEMP ILMN NBIX

The squeeze is on these stocks, and they are poised for volatile moves.

09/14/16 - 06:17 AM EDT

Pet Pharma Is the Newest Growth Sector

Pet Pharma Is the Newest Growth Sector

Tickers in this article: ZTS PFE VRX BAYRY MRK

Zoetis is selling a lineup of drugs for dogs, and that looks to mean big business.

09/09/16 - 04:30 PM EDT

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Tickers in this article: ABT ALR CPHD DHR BSX BCR

Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.

09/07/16 - 07:42 AM EDT

Amgen Has Many Ways to Win

Amgen Has Many Ways to Win

Tickers in this article: AMGN

Investors have been cautious on Amgen, but the company has a strong pipeline of drugs in development.

09/06/16 - 07:55 AM EDT

5 Health Care Stocks John Paulson Is Betting On in 2016

5 Health Care Stocks John Paulson Is Betting On in 2016

Tickers in this article: SHPG MYL AGN TEVA MNK ABBV

When it comes to investing in health care, hedge fund pro John Paulson knows his stuff.

08/31/16 - 08:33 AM EDT

How to Trade These 4 Health Insurers in Uncertain Times

How to Trade These 4 Health Insurers in Uncertain Times

Tickers in this article: AET HUM ANTM CI

Aetna wants to buy Humana and Anthem wants to buy Cigna. Meanwhile, there's Obamacare.

08/31/16 - 06:01 AM EDT

Big Pharma's Punishment in Court of Public Opinion

Big Pharma's Punishment in Court of Public Opinion

Tickers in this article: MYL VRX FB TWTR AZN NVO

Immediate public backlash on social media could end up being a more costly verdict for drugmakers' pricing powers.

08/30/16 - 11:30 AM EDT

Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny

Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny

Tickers in this article: MNK MYL VRX

Short-seller Andrew Left says Mallinckrodt has long been gaming the system on its Acthar Gel drug.

08/25/16 - 10:39 AM EDT

Chinese Plasma Maker China Biologic a Solid Addition for a Portfolio

Chinese Plasma Maker China Biologic a Solid Addition for a Portfolio

Tickers in this article: CBPO

This little-known, Beijing-based drug company is benefiting from accelerating demand for blood substitutes.

08/11/16 - 07:26 AM EDT

Bristol-Myers Offers Strong Risk/Reward Trade Now

Bristol-Myers Offers Strong Risk/Reward Trade Now

Tickers in this article: BMY

Wise investors should not follow analysts who have downgraded Bristol-Myers Squibb, but should instead purchase the stock on sale.

08/09/16 - 07:01 AM EDT

Here's Why Allergan's Earnings Report Could Be Lackluster

Here's Why Allergan's Earnings Report Could Be Lackluster

Tickers in this article: AGN PFE

This drug giant could be on the verge of disappointing investors. Here's why you need to be wary ahead of its operating results on Monday.

08/07/16 - 02:25 PM EDT

Obamacare Still Sickly, After All These Years

Obamacare Still Sickly, After All These Years

Tickers in this article: XPH UNH

Two new reports show how the U.S. healthcare system is falling short, despite six years of Obamacare. Simon Constable explains what's happening and what it means for investors.

08/07/16 - 01:20 PM EDT